Tudor Investment Corp
MRTX

Tudor Investment Corp’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Tudor Investment Corp’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-171,537
Closed -$10.1M – 2915
2023
Q4 		$10.1M Buy
+171,537
New +$9.64M 0.08% 339
2023
Q1 		– Sell
-30,799
Closed -$1.4M – 3072
2022
Q4 		$1.4M Buy
+30,799
New +$1.99M 0.03% 857
2022
Q2 		– Sell
-21,040
Closed -$1.73M – 2615
2022
Q1 		$1.73M Buy
+21,040
New +$2.15M 0.04% 625
2021
Q4 		– Sell
-4,360
Closed -$771K – 3154
2021
Q3 		$771K Sell
4,360
-24,208
-85% -$3.89M 0.01% 1344
2021
Q2 		$4.62M Buy
+28,568
New +$4.59M 0.09% 250
2020
Q4 		– Sell
-16,242
Closed -$2.7M – 1701
2020
Q3 		$2.7M Buy
16,242
+13,383
+468% +$1.83M 0.12% 197
2020
Q2 		$326K Buy
+2,859
New +$277K 0.02% 851
2016
Q4 		– Sell
-15,957
Closed -$105K – 1656
2016
Q3 		$105K Sell
15,957
-29,943
-65% -$159K ﹤0.01% 1334
2016
Q2 		$251K Buy
+45,900
New +$732K 0.01% 1278
2015
Q4 		– Sell
-9,991
Closed -$344K – 1890
2015
Q3 		$344K Buy
+9,991
New +$302K 0.01% 1007

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Tudor Investment Corp's MRTX Position: Q1 2024 in Review

Tudor Investment Corp sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 171,537 shares — an estimated $10.1M sold.

Tudor Investment Corp first reported a position in MRTX in Q3 2015 and held it in 10 quarters. The position peaked at $10.1M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Tudor Investment Corp reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 171,537 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $10.1M.
  • Tudor Investment Corp first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2015 and held it in 10 quarters.
  • Tudor Investment Corp's Mirati Therapeutics, Inc. Common Stock position peaked at $10.1M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Tudor Investment Corp's 13F filing for Q1 2024, filed 15 May 2024.